A1 Refereed original research article in a scientific journal

Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trial




AuthorsOldgren J, Alings M, Darius H, Diener HC, Eikelboom J, Ezekowitz MD, Kamensky G, Reilly PA, Yang S, Yusuf S, Wallentin L, Connolly SJ, Airaksinen J

Publication year2011

JournalAnnals of Internal Medicine

Number in series10

Volume155

Issue10

First page 660

Last page667

Number of pages9

ISSN0003-4819

DOIhttps://doi.org/10.1059/0003-4819-155-10-201111150-00004(external)




Last updated on 2024-26-11 at 18:51